Droice Labs Discusses SuperLineage for Real-World Data Traceability at FDA Listening Session
Droice Labs met with the Food and Drug Administration’s Real-World Evidence Subcommittee in a listening session held on Feb. 2, 2024. The topic of this...
AmplifyBio Completes Acquisition of Intellectual Property to Offer Non-Viral Gene Editing Services for Clients
AmplifyBio, a leading service provider for the commercialization of advanced modality therapeutics, such as cell and gene therapies, today announced the successful acquisition of a...
Contract Pharmacal Corp. Welcomes Glenn Langberg as Chief Strategy Officer
Contract Pharmacal Corp., (CPC), a leading contract development and manufacturing organization (CDMO) for the nutraceutical and pharmaceutical industries, is pleased to welcome Glenn Langberg as Chief Strategy Officer...